The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Walmart Inc. is a major American multinational retail corporation that operates a network of hypermarkets, discount department stores, and grocery outlets across the United States and 23 additional countries. Its headquarters is located in Bentonville, Arkansas. Founded in 1962 by brothers Sam Walton and James "Bud" Walton in nearby Rogers, Arkansas, the company also owns and manages Sam's Club retail warehouses.
As of October 31, 2022, Walmart boasts 10,586 stores and clubs in 24 countries, functioning under 46 distinct brand names. It ranks as the world's largest company by revenue, as listed in the Fortune Global 500 in October 2022. Furthermore, Walmart holds the title of the largest private employer globally, with 2.1 million employees. As a publicly traded family-owned entity, Walmart is primarily governed by the Walton family, whose heirs collectively own over 50 percent of the company through their holding firm, Walton Enterprises, and their individual stakes.
Walmart made its debut on the New York Stock Exchange in 1972. By 1988, it had established itself as the most profitable retailer in the U.S. and achieved the title of the largest in terms of revenue by October 1989. Initially limited geographically to the Southern and lower Midwest regions, Walmart expanded to coast-to-coast stores by the early 1990s. Sam's Club opened its first location in New Jersey in November 1989, and the first California outlet commenced operations in Lancaster in July 1990. A Walmart store in York, Pennsylvania, marked the first main store inauguration in the Northeast in October 1990.
Walmart's international investments have yielded mixed outcomes. Its operations and subsidiaries in Canada, the United Kingdom, Central America, Chile, and China have thrived; however, its efforts in Germany, Japan, South Korea, Brazil, and Argentina have ended in failure.
The company's current financial score is 8.81, which is higher than the Food & Drug Retailing industry's average of 7.09. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 165.61B, representing a year-over-year increase of 2.54%, while its net profit experienced a year-over-year increase of 12.09%.
The company’s current valuation score is 4.80, which is higher than the Food & Drug Retailing industry's average of 2.64. Its current P/E ratio is 36.07, which is 76.42% below the recent high of 63.63 and 0.56% above the recent low of 35.87.
The company’s current earnings forecast score is 8.56, which is higher than the Food & Drug Retailing industry's average of 7.38. The average price target for Walmart Inc is 112.00, with a high of 121.00 and a low of 101.12.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
The company’s current price momentum score is 6.76, which is lower than the Food & Drug Retailing industry's average of 7.21. Sideways: Currently, the stock price is trading between the resistance level at 102.06 and the support level at 92.76, making it suitable for range-bound swing trading.
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
The company’s current institutional recognition score is 7.00, which is lower than the Food & Drug Retailing industry's average of 7.38. The latest institutional shareholding proportion is 81.55%, representing a quarter-over-quarter decrease of 0.92%. The largest institutional shareholder is The Vanguard, holding a total of 429.97M shares, representing 5.39% of shares outstanding, with 2.82% increase in holdings.
The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Food & Drug Retailing domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The company’s current risk assessment score is 5.88, which is higher than the Food & Drug Retailing industry's average of 4.61. The company's beta value is 0.67. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.
The Stock Score data is powered by TradingKey and updated daily. Rating data is sourced from LESG. Please use the data with caution for reference purposes only.